SCHEMBL4254312

SCHEMBL4254312

Cc1ccc(S(=O)(=O)OC2=C(Br)C(=O)c3ccc4c(c3C2=O)CCC(C)(C)O4)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MALT1 Q9UDY8 2/20 0.34
▸ DHODH Q02127 1/20 0.34
▸ CNR2 P34972 1/20 0.34
▸ PKM P14618 2/20 0.33
▸ IDO1 P14902 2/20 0.33
▸ ELANE P08246 1/20 0.33
▸ PRTN3 P24158 1/20 0.33
▸ PKLR P30613 1/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ CES2 O00748 1/20 0.33
▸ GMNN O75496 1/20 0.33
▸ TDP2 O95551 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4258552 0.96 DHODH (0.36) MALT1DHODHCNR2PKMIDO1
SCHEMBL4253991 0.73 DHODH (0.37) DHODHCNR2IDO1ELANEPRTN3
SCHEMBL4251719 0.72 MALT1 (0.39) MALT1IDO1CYP2C19KDM4EMEN1
SCHEMBL22965205 0.65 MALT1 (0.37) MALT1CNR2MAPTNFKB1NFKB2
SCHEMBL4251143 0.64 MALT1 (0.40) MALT1IDO1CYP2C19KDM4EMEN1
SCHEMBL4251170 0.64 AURKA (0.38) MALT1IDO1CYP2C19KDM4EMEN1
SCHEMBL30061363 0.59 ALDH1A1 (0.56) KDM4EMEN1ALDH1A1LMNAMAPT
SCHEMBL18263184 0.59 ALDH1A1 (0.51) KDM4EMEN1ALDH1A1LMNAMAPT
SCHEMBL10893316 0.59 GAA (0.54) PKMELANEPRTN3CYP2C19MEN1
SCHEMBL23148916 0.59 PKM (0.44) PKMPKLRCYP2C19ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090170926-A1 Antiviral agents MONASH UNIVERISTY (AU) 2009-07-02 — — US claimed
US-20090170926-A1 Antiviral agents MONASH UNIVERISTY (AU) 2009-07-02 — — US disclosed
US-20090170926-A1 Antiviral agents MONASH UNIVERISTY (AU) 2009-07-02 — — US disclosed
US-20090170926-A1 Antiviral agents MONASH UNIVERISTY (AU) 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170926-A1 Antiviral agents SLC10A1, HAVCR2, ZC3HAV1 MALT1 1025/4885DHODH 757/4885CNR2 3686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback